Pooled Safety and Tolerability Analysis of Empagliflozin in Patients with Type 2 Diabetes Mellitus

INTRODUCTION: The aim of this analysis was to characterize the safety and tolerability of empagliflozin in patients with type 2 diabetes mellitus (T2DM) who were randomized to empagliflozin (10/25 mg) or placebo in clinical trials. METHODS: Pooled data from 20 trials were analyzed for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinduryte Schorling, Ona, Clark, Douglas, Zwiener, Isabella, Kaspers, Stefan, Lee, Jisoo, Iliev, Hristo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370973/
https://www.ncbi.nlm.nih.gov/pubmed/32372290
http://dx.doi.org/10.1007/s12325-020-01329-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7370973/
https://www.ncbi.nlm.nih.gov/pubmed/32372290
http://dx.doi.org/10.1007/s12325-020-01329-7

Ejemplares similares